ELTX Elicio Therapeutics, Inc.
Fundamentals / CIK 0001601485 / USDElicio Therapeutics, Inc. reported $39.60M in total assets and a net loss of $35.74M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$38.33M Operating profit
-
Net Income FY 2025-$35.74M GAAP bottom line
-
Diluted EPS FY 2025-$1.36 Split-adjusted
-
Free Cash Flow FY 2025-$36.97M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$30.90M Total debt: $13.99M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.30M | $28.31M | $2.88M |
| Cost of Revenue | -- | -- | -- | $0 | $433K | $1.19M |
| Gross Profit | -- | -- | -- | $2.30M | $27.88M | $1.69M |
| Research & Development | $24.90M | $33.66M | $23.85M | $18.10M | $48.70M | $38.98M |
| Operating Income | -$37.71M | -$44.99M | -$35.74M | -$23.73M | -$39.31M | -$55.27M |
| EBITDA | -$37.51M | -$44.66M | -$35.36M | -$23.34M | -$39.22M | -$55.17M |
| Interest Expense | $1.13M | $455K | $1.06M | $3.60M | -- | -- |
| Income Before Tax | -$39.57M | -$51.90M | -- | -$38.80M | -$54.57M | -$80.11M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$39.57M | -$51.90M | -$35.20M | -$28.21M | -$54.57M | -$80.11M |
| Basic EPS | -$2.58 | -$4.25 | -$6.96 | -$188.89 | -$4.08 | -$11.49 |
| Diluted EPS | -$2.58 | -$4.25 | -$6.96 | -$188.89 | -$4.08 | -$11.49 |
| Basic Shares Outstanding | 15.3M | 12.2M | 5.1M | 149.3K | 13.3M | 7.0M |
| Diluted Shares Outstanding | 15.3M | 12.2M | 5.1M | 149.3K | 13.3M | 7.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $4.89M | $6.81M | $6.76M | $5.08M | $5.04M | $7.01M | $7.78M | $10.71M |
| Operating Income | -$8.45M | -$10.43M | -$10.60M | -$8.84M | -$8.04M | -$10.09M | -$10.74M | -$13.48M |
| EBITDA | -$8.45M | -$10.33M | -$10.56M | -$8.79M | -$7.95M | -$9.99M | -$10.68M | -$13.39M |
| Interest Income | $237K | $138K | $157K | -- | $199K | $168K | $210K | -- |
| Interest Expense | $413K | $410K | $407K | $337K | $426K | $194K | $176K | $234K |
| Income Before Tax | -$7.92M | -- | -- | -- | -$10.08M | -- | -- | -- |
| Income Tax Expense | $55K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7.98M | -$8.22M | -$11.82M | -$7.72M | -$10.08M | -$10.56M | -$11.21M | -$14.00M |
| Basic EPS | -$0.30 | -$0.43 | -$0.65 | -- | -$0.60 | -$0.66 | -$0.87 | -- |
| Diluted EPS | -$0.30 | -$0.43 | -$0.65 | -- | -$0.60 | -$0.66 | -$0.87 | -- |
| Basic Shares Outstanding | 26.3M | 19.2M | 18.2M | -- | 16.7M | 16.1M | 13.0M | -- |
| Diluted Shares Outstanding | 26.3M | 19.2M | 18.2M | -- | 16.7M | 16.1M | 13.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $18.56M | $17.62M | $12.89M | $6.16M | $88.76M | $34.61M |
| Cash & Short-Term Investments | $18.56M | $17.62M | $12.89M | $6.16M | $88.76M | $34.61M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- |
| Other Current Assets | -- | -- | -- | $246K | $498K | $360K |
| Total Current Assets | $19.31M | $20.69M | $16.35M | $10.72M | $91.25M | $42.30M |
| Property, Plant & Equipment, Net | $295K | $483K | $717K | $1.15M | $451K | $156K |
| Other Non-Current Assets | -- | -- | -- | $61K | $106K | $0 |
| Total Non-Current Assets | $6.55M | $7.49M | $10.80M | $11.95M | $5.27M | $5.05M |
| Total Assets | $25.86M | $28.18M | $27.15M | $22.66M | $96.51M | $47.35M |
| Accounts Payable | $672K | $1.04M | $4.37M | $2.81M | $4.71M | $5.58M |
| Short-Term Debt | $0 | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $0 | $1.17M | $694K | $1.44M | $2.30M | $3.94M |
| Total Current Liabilities | $8.11M | $11.52M | $9.76M | $6.87M | $11.30M | $107.4M |
| Long-Term Debt | $9.41M | $20.03M | -- | -- | $0 | $635K |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $0 | $25.86M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $0 | -- |
| Total Non-Current Liabilities | $16.12M | $27.97M | $6.02M | $6.88M | $3.71M | $30.35M |
| Total Liabilities | $24.23M | $39.49M | $15.77M | $13.75M | $15.01M | $137.8M |
| Total Debt (incl. Leases) | $14.51M | $26.04M | $6.92M | $3.71M | $4.66M | $5.09M |
| Common Stock | $178K | $110K | $96K | $3.0K | $300K | $156K |
| Retained Earnings | -$233.7M | -$194.1M | -$142.2M | -$107.0M | -$215.1M | -$160.6M |
| Accumulated Other Comp. Income | -$127K | -$175K | -$197K | $0 | -$103K | -$333K |
| Total Stockholders' Equity | $1.64M | -$11.31M | $11.37M | -$102.1M | -$74.54M | -$90.45M |
| Total Equity | $1.64M | -$11.31M | $11.37M | -$102.1M | -$74.54M | -$90.45M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $30.90M | $23.48M | $14.95M | $18.56M | $20.61M | $22.09M | $18.35M | $17.62M |
| Cash & Short-Term Investments | $30.90M | $23.48M | $14.95M | $18.56M | $20.61M | $22.09M | $18.35M | $17.62M |
| Total Current Assets | $34.03M | $25.48M | $16.20M | $19.31M | $21.46M | $22.60M | $20.93M | $20.69M |
| Property, Plant & Equipment, Net | $182K | $213K | $249K | $295K | $328K | $377K | $430K | $483K |
| Total Non-Current Assets | $5.56M | $5.84M | $6.49M | $6.55M | $6.82M | $6.93M | $7.21M | $7.49M |
| Total Assets | $39.60M | $31.33M | $22.69M | $25.86M | $28.28M | $29.53M | $28.14M | $28.18M |
| Accounts Payable | $379K | $839K | $272K | $672K | $321K | $3.87M | $4.04M | $1.04M |
| Short-Term Debt | $2.48M | -- | -- | $0 | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | $0 | $680K | $1.17M |
| Total Current Liabilities | $9.93M | $9.20M | $7.23M | $8.11M | $6.51M | $9.92M | $11.41M | $11.52M |
| Long-Term Debt | $7.16M | $9.54M | $9.47M | $9.41M | $9.72M | $9.34M | -- | $20.03M |
| Total Non-Current Liabilities | $10.81M | $14.19M | $16.90M | $16.12M | $17.95M | $17.77M | $7.83M | $27.97M |
| Total Liabilities | $20.75M | $23.39M | $24.13M | $24.23M | $24.47M | $27.69M | $19.24M | $39.49M |
| Total Debt (incl. Leases) | $13.99M | $14.15M | $14.34M | $14.51M | $15.06M | $14.90M | $5.79M | $26.04M |
| Common Stock | $283K | $219K | $186K | $178K | $173K | $163K | $160K | $110K |
| Retained Earnings | -$261.7M | -$253.7M | -$245.5M | -$233.7M | -$226.0M | -$215.9M | -$205.3M | -$194.1M |
| Accumulated Other Comp. Income | -$127K | -$126K | -$122K | -$127K | -$31K | -$70K | -$144K | -$175K |
| Total Stockholders' Equity | $18.85M | $7.94M | -$1.44M | $1.64M | $3.82M | $1.83M | $8.90M | -$11.31M |
| Total Equity | $18.85M | $7.94M | -$1.44M | $1.64M | $3.82M | $1.83M | $8.90M | -$11.31M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$39.57M | -$51.90M | -$35.20M | -$28.21M | -$54.57M | -$80.11M |
| Depreciation & Amortization | $204K | $321K | $382K | $390K | $91K | $98K |
| Stock-Based Compensation | $2.70M | $1.45M | $1.18M | $579K | $12.04M | $4.72M |
| Change in Payables | -$366K | -$3.33M | $23K | $1.12M | -$866K | -$5.61M |
| Operating Cash Flow | -$36.95M | -$37.07M | -$32.69M | -$22.18M | -$52.64M | -$22.89M |
| Capital Expenditure | -$16K | -$87K | -$66K | -$654K | -$382K | -$41K |
| Free Cash Flow | -$36.97M | -$37.16M | -$32.76M | -$22.83M | -$53.02M | -$22.93M |
| Investing Cash Flow | -$16K | -$84K | -$32K | -$654K | -$382K | -$41K |
| Common Stock Issued | $16.24M | $4.55M | $7.00M | $0 | $107.5M | -$522K |
| Share Repurchases | -- | $0 | -$150K | $0 | -- | -- |
| Financing Cash Flow | $36.70M | $42.32M | $38.61M | $21.20M | $107.2M | $52.41M |
| Net Change in Cash | -$225K | $5.19M | $5.89M | -$1.63M | $54.15M | $29.04M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.98M | -$8.22M | -$11.82M | -$7.72M | -$10.08M | -$10.56M | -$11.21M | -$14.00M |
| Depreciation & Amortization | $0 | $100K | $46K | $49K | $100K | $100K | $53K | $85K |
| Stock-Based Compensation | $1.11M | $935K | $868K | $772K | $698K | $710K | $517K | $464K |
| Change in Payables | -$460K | $627K | -$460K | $351K | -$3.54M | -$172K | $3.00M | -$946K |
| Operating Cash Flow | -$10.36M | -$8.16M | -$11.64M | -$6.80M | -$11.09M | -$8.95M | -$10.12M | -$8.74M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -$45K |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -$8.79M |
| Investing Cash Flow | -- | -- | -- | -$16K | $0 | $0 | $0 | -$45K |
| Common Stock Issued | -- | -- | -- | $16.24M | -$2.85M | $2.02M | $835K | -$858K |
| Financing Cash Flow | $17.79M | $16.51M | $8.03M | $4.86M | $9.57M | $11.93M | $10.33M | $227K |
| Net Change in Cash | $7.42M | $8.34M | -$3.61M | -$2.05M | -$1.48M | $3.06M | $240K | -$8.54M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 100.0% | 98.5% | 58.7% |
| Operating Margin | -- | -- | -- | -1031.4% | -138.8% | -1919.2% |
| Net Profit Margin | -- | -- | -- | -1225.9% | -192.8% | -2781.5% |
| Return on Equity (ROE) | -2418.8% | -- | -309.5% | -- | -- | -- |
| Return on Assets (ROA) | -153.0% | -184.2% | -129.7% | -124.5% | -56.5% | -169.2% |
| Current Ratio | 2.38x | 1.80x | 1.68x | 1.56x | 8.08x | 0.39x |
| Quick Ratio | 2.29x | 1.53x | 1.32x | 0.90x | 7.86x | 0.32x |
| Debt to Equity | 8.87x | -- | 0.61x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -- | -- | -91.9% | +883.1% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -91.7% | +1549.6% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -189.6% | -476.8% | -- | -2418.8% | -1201.7% | -2977.8% | -575.9% | -- |
| Return on Assets (ROA) | -90.3% | -120.8% | -177.1% | -153.0% | -162.1% | -184.9% | -182.2% | -184.2% |
| Current Ratio | 3.43x | 2.77x | 2.24x | 2.38x | 3.29x | 2.28x | 1.83x | 1.80x |
| Quick Ratio | 3.11x | 2.55x | 2.07x | 2.29x | 3.16x | 2.23x | 1.61x | 1.53x |
| Debt to Equity | 0.74x | 1.78x | -- | 8.87x | 3.95x | 8.13x | 0.65x | -- |